Mastalgia (Breast Pain) Global Clinical Trials Review, H2, 2017

Pages: 65 Published: December 15, 2017 Report Code: GDHC4763CTIDB

  • Overview
  • Key Players
  • Contents
  • Tables
  • Figures
  • Listen
    Text to Speech

GlobalData's clinical trial report, “Mastalgia (Breast Pain) Global Clinical Trials Review, H2, 2017" provides an overview of Mastalgia (Breast Pain) clinical trials scenario. This report provides top line data relating to the clinical trials on Mastalgia (Breast Pain). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Key Players

Symbollon Pharmaceuticals Inc (Inactive)

Besins Healthcare SA

BioPharmX Corporation

Bionorica SE

Atossa Genetics Inc

FemmePharma Global Healthcare Inc

Esba Laboratories Inc

Biosearch Life

Baxter International Inc

AstraZeneca Plc

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Mastalgia (Breast Pain) to Central Nervous System Clinical Trials 16

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Mastalgia (Breast Pain) to Central Nervous System Clinical Trials 20

Clinical Trials by Phase in E7 Countries 22

Clinical Trials in E7 Countries by Trial Status 23

Clinical Trials by Phase 24

In Progress Trials by Phase 25

Clinical Trials by Trial Status 26

Clinical Trials by End Point Status 28

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Mastalgia (Breast Pain) Therapeutics Clinical Trials 33

Prominent Drugs 35

Clinical Trial Profile Snapshots 36

Appendix 62

Abbreviations 62

Definitions 62

Research Methodology 63

Secondary Research 63

About GlobalData 64

Contact Us 64

Source 65

List of Tables

Mastalgia (Breast Pain) Therapeutics, Global, Clinical Trials by Region, 2017* 7

Mastalgia (Breast Pain) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

Mastalgia (Breast Pain) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 11

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12

Mastalgia (Breast Pain) Therapeutics Clinical Trials, North America, Top Countries, 2017* 13

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15

Proportion of Mastalgia (Breast Pain) to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 16

Mastalgia (Breast Pain) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18

Mastalgia (Breast Pain) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19

Proportion of Mastalgia (Breast Pain) to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 20

Mastalgia (Breast Pain) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22

Mastalgia (Breast Pain) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23

Mastalgia (Breast Pain) Therapeutics, Global, Clinical Trials by Phase, 2017* 24

Mastalgia (Breast Pain) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 25

Mastalgia (Breast Pain) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 28

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 29

Mastalgia (Breast Pain) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 30

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35

List of Figures

Mastalgia (Breast Pain) Therapeutics, Global, Clinical Trials by Region (%), 2017* 7

Mastalgia (Breast Pain) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

Mastalgia (Breast Pain) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 11

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12

Mastalgia (Breast Pain) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14

Proportion of Mastalgia (Breast Pain) to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 16

Mastalgia (Breast Pain) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18

Mastalgia (Breast Pain) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19

Proportion of Mastalgia (Breast Pain) to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 20

Mastalgia (Breast Pain) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22

Mastalgia (Breast Pain) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23

Mastalgia (Breast Pain) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 24

Mastalgia (Breast Pain) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 25

Mastalgia (Breast Pain) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 28

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 29

Mastalgia (Breast Pain) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 30

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33

Mastalgia (Breast Pain) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35

GlobalData Methodology 63

$2500

Can be used by individual purchaser only

$7500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.